Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$668M |
| 2 |
Chevron
CVX
|
+$626M |
| 3 |
NVIDIA
NVDA
|
+$567M |
| 4 |
Microsoft
MSFT
|
+$538M |
| 5 |
CRH
CRH
|
+$534M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$599M |
| 2 |
Intel
INTC
|
+$509M |
| 3 |
Eli Lilly
LLY
|
+$240M |
| 4 |
Analog Devices
ADI
|
+$239M |
| 5 |
EOG Resources
EOG
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.61% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Financials | 10.25% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Plains All American Pipeline
PAA
$17.4B
| $3M | ﹤0.01% |
194,305
| – | – |
|
1027
Ziff Davis
ZD
$1.9B
| $3M | ﹤0.01% |
48,551
+11,595
| +31% | +$795K |
|
1028
Phillips Edison & Co
PECO
$5.48B
| $3M | ﹤0.01% |
87,942
-2,574
| -3% | -$89K |
|
1029
Rapid7
RPD
$634M
| $2.97M | ﹤0.01% |
60,235
+15,622
| +35% | +$721K |
|
1030
Exelixis
EXEL
$13.9B
| $2.96M | ﹤0.01% |
138,462
+42,411
| +44% | +$887K |
|
1031
Voya Financial
VOYA
$8.94B
| $2.94M | ﹤0.01% |
44,613
+24,029
| +117% | +$1.71M |
|
1032
iShares MSCI Taiwan ETF
EWT
$10B
| $2.94M | ﹤0.01% |
64,500
| – | – |
|
|
CGAU
1033
Centerra Gold
CGAU
$3.22B
| $2.93M | ﹤0.01% |
606,063
-545,700
| -47% | -$3.19M |
|
1034
iShares MSCI Poland ETF
EPOL
$669M
| $2.93M | ﹤0.01% |
163,700
| – | – |
|
|
AAMI
1035
Acadian Asset Management
AAMI
$2.88B
| $2.92M | ﹤0.01% |
168,675
-20,004
| -11% | -$413K |
|
1036
Concentrix
CNXC
$1.36B
| $2.92M | ﹤0.01% |
36,878
+9,485
| +35% | +$744K |
|
1037
FirstService
FSV
$6.32B
| $2.9M | ﹤0.01% |
20,300
+2,549
| +14% | +$389K |
|
|
HFRO
1038
Highland Opportunities and Income Fund
HFRO
$407M
| $2.82M | ﹤0.01% |
367,181
| – | – |
|
|
PLL
1039
DELISTED
Piedmont Lithium
PLL
| $2.82M | ﹤0.01% |
85,622
-3,663
| -4% | -$178K |
|
1040
Stride
LRN
$3.69B
| $2.81M | ﹤0.01% |
62,031
-53,692
| -46% | -$2.18M |
|
1041
Brookfield Asset Management
BAM
$74B
| $2.78M | ﹤0.01% |
85,670
-17,718
| -17% | -$598K |
|
|
UDMY
1042
DELISTED
Udemy
UDMY
| $2.77M | ﹤0.01% |
291,020
+138,004
| +90% | +$1.44M |
|
1043
Boise Cascade
BCC
$2.74B
| $2.77M | ﹤0.01% |
29,387
+503
| +2% | +$51.8K |
|
|
SKE
1044
Skeena Resources
SKE
$3.36B
| $2.76M | ﹤0.01% |
607,700
+22,400
| +4% | +$109K |
|
|
DESP
1045
DELISTED
Despegar.com
DESP
| $2.7M | ﹤0.01% |
405,292
+170,813
| +73% | +$1.29M |
|
1046
Indivior Pharmaceuticals
INDV
$4.79B
| $2.69M | ﹤0.01% |
+138,880
| New | +$3.17M |
|
1047
Frontdoor
FTDR
$5.02B
| $2.69M | ﹤0.01% |
87,364
+77,003
| +743% | +$2.55M |
|
1048
Sabra Healthcare REIT
SBRA
$5.64B
| $2.67M | ﹤0.01% |
187,638
+9,272
| +5% | +$119K |
|
1049
Vista Energy
VIST
$7.75B
| $2.67M | ﹤0.01% |
85,881
-520,150
| -86% | -$13.6M |
|
1050
Stem
STEM
$49.2M
| $2.66M | ﹤0.01% |
34,744
-698
| -2% | -$79.7K |
|
Similar funds
Amundi's Q3 2023 Portfolio in Review
As of Q3 2023, Amundi held 2,094 positions worth $203B, up 2.9% from $198B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi deployed $11.1B of net new capital in Q3 2023, opening 69 new positions and adding to 881 existing holdings. Its largest new stake was Kenvue: 14,174,156 shares worth $275M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $599M trimmed.
- Amundi's largest Q3 2023 buy was Kenvue: 14,174,156 shares worth $275M.
- Amundi added most to UnitedHealth in Q3 2023, an estimated $668M increase.
- Amundi's biggest Q3 2023 reduction was Advanced Micro Devices, cutting an estimated $599M.
- Amundi fully exited Elanco Animal Health in Q3 2023, selling an estimated $25.3M.
- Amundi's ten largest holdings make up 23% of its $203B portfolio in Q3 2023.
- Amundi opened 69 new positions and closed 87 in Q3 2023.
- Amundi's portfolio value rose 2.9% quarter-over-quarter to $203B.
Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.